Information Provided By:
Fly News Breaks for January 2, 2019
RARE
Jan 2, 2019 | 07:51 EDT
As previously reported, Raymond James downgraded Ultragenyx to Market Perform from Outperform. Analyst Laura Chico said Ultragenyx lacks near-term catalysts which makes it more vulnerable in a "risk off" environment. Chico remains encouraged by the Crysvita launch, but said the company is only proportion of the economics.